{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:27:39Z","timestamp":1761895659348,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009520","name":"Rick Hansen Institute","doi-asserted-by":"publisher","award":["2010-01"],"award-info":[{"award-number":["2010-01"]}],"id":[{"id":"10.13039\/100009520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000049","name":"Ontario Neurotrauma Foundation","doi-asserted-by":"publisher","award":["2007-SCI-SCIRE-528"],"award-info":[{"award-number":["2007-SCI-SCIRE-528"]}],"id":[{"id":"10.13039\/501100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.apmr.2013.04.011","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T13:16:51Z","timestamp":1367155011000},"page":"1473-1481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Meta-Analysis of Botulinum Toxin A Detrusor Injections in the Treatment of Neurogenic Detrusor Overactivity After Spinal Cord Injury"],"prefix":"10.1016","volume":"94","author":[{"given":"Swati","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norine","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ethans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Teasell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldon","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blayne","family":"Welk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalton","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2013.04.011_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.curobgyn.2004.07.004","article-title":"Detrusor overactivity","volume":"14","author":"Majumdar","year":"2004","journal-title":"Curr Obstet Gynaecol"},{"key":"10.1016\/j.apmr.2013.04.011_bib2","first-page":"44","article-title":"Botulinum toxin A in the treatment of neurogenic and idiopathic urinary incontinence","volume":"9","author":"Morrisroe","year":"2007","journal-title":"Rev Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib3","first-page":"527","article-title":"Bladder management for adults with spinal cord injury. A clinical practice guideline for health care providers","volume":"29","author":"Paralyzed Veterans of America","year":"2006","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.apmr.2013.04.011_bib4","doi-asserted-by":"crossref","unstructured":"American Urological Association. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline. 2012. Available at: http:\/\/www.auanet.org\/content\/media\/OAB_guideline.pdf. Accessed February 12, 2013.","DOI":"10.1016\/j.yuro.2013.02.008"},{"key":"10.1016\/j.apmr.2013.04.011_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","article-title":"Molecular pharmacology of botulinum toxin and tetanus toxin","volume":"26","author":"Simpson","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apmr.2013.04.011_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ucl.2004.09.005","article-title":"Injectable neuromodulatory agents: botulinum toxin therapy","volume":"32","author":"Frenkl","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.apmr.2013.04.011_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apmr.2013.04.011_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.sc.3102070","article-title":"Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects","volume":"45","author":"MacDonald","year":"2007","journal-title":"Spinal Cord"},{"key":"10.1016\/j.apmr.2013.04.011_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10790268.2008.11760706","article-title":"Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects","volume":"31","author":"MacDonald","year":"2008","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.apmr.2013.04.011_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.apmr.2011.11.020","article-title":"A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury","volume":"93","author":"Mehta","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2013.04.011_bib13","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, 2011. Available at: http:\/\/www.cochrane-handbook.org. Accessed August 21, 2012."},{"year":"1988","series-title":"Statistical power and analysis for behavioural sciences","author":"Cohen","key":"10.1016\/j.apmr.2013.04.011_bib14"},{"year":"2001","series-title":"Practical meta-analysis","author":"Lipsey","key":"10.1016\/j.apmr.2013.04.011_bib15"},{"key":"10.1016\/j.apmr.2013.04.011_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2009.08466.x","article-title":"Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study","volume":"104","author":"Grosse","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.apmr.2013.04.011_bib18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Game","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of Botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib21","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2013.04.011_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","article-title":"Therapeutic effects of suburothelial injection of botulinum A toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions","volume":"67","author":"Kuo","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.apmr.2013.04.011_bib23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.urology.2008.04.026","article-title":"Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin A injection","volume":"72","author":"Kuo","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.apmr.2013.04.011_bib24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","article-title":"Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction","volume":"104","author":"Pannek","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.apmr.2013.04.011_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.47102\/annals-acadmedsg.V36N1p11","article-title":"Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord patients in Singapore","volume":"36","author":"Tow","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.apmr.2013.04.011_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00345-009-0466-1","article-title":"Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX\u00ae) therapy in Germany","volume":"28","author":"Wefer","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","article-title":"Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction","volume":"100","author":"Akbar","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.apmr.2013.04.011_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","article-title":"Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury","volume":"98","author":"Patki","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.apmr.2013.04.011_bib29","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","article-title":"Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder","volume":"181","author":"Flynn","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.sc.3102104","article-title":"A novel technique to achieve cutaneous continent urinary diversion in spinal cord injured patients unable to catheterize through native urethra","volume":"46","author":"Karsenty","year":"2008","journal-title":"Spinal Cord"},{"key":"10.1016\/j.apmr.2013.04.011_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","article-title":"Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema, and fibrosis with and without injection of botulinum toxin type A","volume":"50","author":"Comperat","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin\u00a0type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1442-2042.2008.02016.x","article-title":"Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure","volume":"15","author":"Schulte-Baukloh","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.apmr.2013.04.011_bib34","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/mds.23254","article-title":"Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX\u00ae) across multiple indications","volume":"25","author":"Naumann","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.apmr.2013.04.011_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2051415812473096","article-title":"Botulinum toxin-A for the treatment of overactive bladder: UK contributions","volume":"6","author":"Seth","year":"2013","journal-title":"J Clin Urol"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999313003171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999313003171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:57:26Z","timestamp":1757746646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999313003171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0003999313003171"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2013.04.011","relation":{},"ISSN":["0003-9993"],"issn-type":[{"type":"print","value":"0003-9993"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Botulinum Toxin A Detrusor Injections in the Treatment of Neurogenic Detrusor Overactivity After Spinal Cord Injury","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2013.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}